Shire's latest acquisition, of Canada's BioChem Pharma, is its sixth in as many years, and the clearest sign yet of the shift which the UK-based specialty pharmaceutical company has to make towards ea
Multiple attacks on a multi-faceted disease Watching a friend or family member deteriorate as a result of senile dementia of the Alzheimer's type, also called Alzheimer's disease (AD), is excruciating